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1. Background 
 
 
Studies have reported that there is a significant relationship between hospital 
infections and bioaerosols. 
(Lim et al. 2010) 
Fungi are present in clinical indoor environments and play important roles in 
human diseases in patients and staff.  
(Lal et al. 2017) 
Aspergillus is a common fungus in invasive infections, however, other fungi are 
enrolled as pathogens in immunosuppressed patients. 
(Knibbs et al. 2011) 
The azole-resistant Aspergillus sp. has up to 30% prevalence in some European 
hospitals, which report higher than 90% mortality rates. 
(Van Paassen et al. 2016) 
 
Control measures are crucial in clinical environments for reducing concen-
trations of airborne fungal contamination and to avoid invasive infections 
acquired from indoor air. 
(Pfaller & Diekema 2010) 
We cannot fully eliminate fungi from indoor clinical environments and 
enforcement is needed to ensure, at least, proper Indoor Air Quality (IAQ) 
assessments. 
(Liu et al. 2017) 
 
Portuguese legislation established limit values for air bioburden in indoor 
environments in general, without any specific requirement for health care 
facilities.  
Table 1. Portuguese legal compliance for mycobiota according to Ordinance no. 359-A/2013. 
 
  Fungi 
1
st
 requirement    [indoor] < [outdoor] 
2
nd
 requirement (to be applied when 
the 1
st
 requirement is not fulfilled) 
  No visible fungal growth on 
surfaces;  
 Species should be evaluated 
according Table 2 
 
Table 1. Fungal conformity based on the species according to Ordinance no. 359-A/2013. 
 
Genera/Species Specific Condition of Conformity 
Common species Cladosporium sp. 
Penicillium sp. 
Aspergillus sp. 
Alternaria sp. 
Eurotium spp 
Paecilomyces sp. 
Wallemia sp. 
Mixture of species: ≤ 500 CFU.m-3 
 
Non-common 
species 
Acremonium sp. 
Chrysonilia sp. 
Tricothecium sp. 
Curvularia sp. 
Nigrospora sp. 
One species: < 50 CFU.m
-3
 
Mixture of species: < 150 CFU.m
-3
 
Pathogenic 
species 
Chryptococcus 
neoformans 
Histoplasma 
capsulatum 
Blastomyces 
dermatitidis 
Coccidioides immitis 
Absence of any species 
Toxigenic species Stachybotrys 
chartarum 
Aspergillus versicolor 
Aspergillus flavus 
Aspergillus ochraceus 
Aspergillus terreus 
Aspergillus fumigatus 
Fusarium moniliforme 
Fusarium culmorum 
Trichoderma viride 
One species:  < 12 CFU.m
-3
 (Several 
colonies per plate) 
 
 
 
 This study focuses on the mycobiota assessment in 10 
Primary Health Care Centers (PHCC) applying the IAQ 
Portuguese legislation as guidance.  
 
 
 After the quantitative cut-off analyses (I/O) the fungal species 
identification was performed to verify if the fungal 
conformity was achieved even in those that comply with the 
I/O ratio. 
2. Materials and methods 
Waiting room, treatments 
room, vaccination room, back 
and front office, medical 
office, cleaning supplies 
room, oral hygiene office, 
sterilization, and canteen 
Other performed assessments in the 
same matrices: 
 Fungal biomass 
 Toxigenic fungal strains detection 
 MRSA prevalence (all passive 
methods) 
 Azole resistance prevalence among 
the recovered mycobiota 
 Mycotoxins 
 Endotoxins 
 
 
 
The median values on MEA ranged from 164 CFU.m-3 (in the clean area of the 
sterilization room) to 508 CFU.m-3 (in the treatments room). Among the 10 
PHCC 60% (6 out of 10) presented I/O >1. 
 
 
 
3. Results 
 Aspergillus sections Versicolores, 
Circumdati and Fumigati were 
identified on air 
 
 > 12 CFU.m-3  
- Section Versicolores surpassed in 
PHCC 2, 3 and 6.  
- Section Circumdati the load was 
surpassed in PHCC 2  
- Section Fumigati in PHCC 5. 
 
 Sections Nigri, Aspergilli and 
Nidulantes were also observed. 
 
PHCC 
Mean 
(CFU.m
-3
) 
Outdoor                 
(CFU.m
-3
) 
I/O Toxigenic species* 
1 28.57 144 0.20  
2 65 20 3.25 
Aspergillus sections Circumdati 
and Versicolores 
3 479 612 0.78 Aspergillus section Versicolores 
4 402 260 1.55  
5 291 96 3.03 Aspergillus section Fumigati 
6 155.5 228 0.68 Aspergillus section Versicolores 
7 474.91 140 3.39  
8 526 384 1.37  
9 505.71 508 1.00  
10 520 208 2.50  
* Not complying with specific condition of conformity 
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30ºC for 5 to 7 days 
Inoculation in dichloran glycerol (DG18) agar-based 
media, incubation at 30ºC for 5 to 7 days 
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Mycobiota assessment should be always performed: 
  to verify compliance with Portuguese legislation;  
 fungal infections predominantly occur in immunocompromised 
patients and many are acquired in hospitals; 
 Aspergillus genus should always be target in clinical 
environment and should be considered as a main IAQ concern. 
 
(ACGIH 1999; Patterson 2016) 
 
4. Main findings discussion 
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Even if the I/O ratio cut-off is in accordance with legislation 
 
 
Qualitative assessment from the fungal burden (fungal 
species/sections identification) should be performed 
 
 
Since toxigenic species can be present 
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 Assessment should not be restrictive to the listed fungal species, since not 
all fungal/species with toxigenic potential, and common in indoor 
environments from Portugal, are listed (Aspergillus sections Nigri, 
Aspergilli and Nidulantes were also isolated).  
 
 
 Portuguese legislation only relies on active methods (air sampling) and this 
can narrow the exposure assessment. 
  
(Gralton et al. 2011) 
Other critical points from Portuguese legislation: 
 
Take home messages (with further results):  
 
 
 A multi-approach in the sampling methods (active and passive) 
and analyses applied should be the trend.  
 
 
More refined risk characterization 
 
 
Suitable risk control measures to reduce patients and workers 
health outcomes. 
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The quantitative cut-off applied to assess IAQ is not a suitable 
surrogate to ensure an IAQ regarding the mycobiota in health 
care facilities. 
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